Search - tctmd.com

Displaying 41 - 60 of 641

Sort: Relevancy | Date

Presentation TCT 2016

BIONICS: A Prospective, Randomized Trial of a Ridaforolimus-Eluting Coronary Stent vs a Zotarolimus-Eluting Stent in a More-Comers Population of Patients With Coronary Artery Disease

Presenter: Gregg W. Stone, Wayne B. Batchelor, David E. Kandzari

October 30, 2016

Presentation TCT 2016

BIO-RESORT (TWENTE III): A Prospective, Randomized Three-Arm Trial Comparing Two Different Biodegradable Polymer-Based Drug-Eluting Stents and a Durable Polymer-Based Drug-Eluting Stent in an All-Comers Population of Patients With Coronary Artery Disease

Presenter: Gregg W. Stone, Wayne B. Batchelor, Clemens von Birgelen

October 30, 2016

Presentation TCT 2016

ILUMIEN III (OPTIMIZE PCI): A Prospective, Randomized Trial of OCT-Guided vs IVUS-Guided vs Angio-Guided Stent Implantation in Patients With Coronary Artery Disease

Presenter: Gregg W. Stone, Wayne B. Batchelor, Ziad A. Ali

October 30, 2016

News Opinion Editor's Corner TCT 2016

TCT 2016: Inspiration and Perspiration Greet Left Main Stenting, Hoop Dreams, Valve Innovation, and Election Fever

Shelley Wood

October 24, 2016

News Conference News ESC 2016

Day or Night, STEMI Patients Receive Similar Levels of Quality Care

L.A. McKeown

August 31, 2016

News Conference News ESC 2016

NORSTENT: Do Modern-day Bare-Metal Stents Stand Up to Drug-Eluting Stents?

Shelley Wood

August 30, 2016

News Daily News

One Map to Guide Them All: The Physician Who Hopes to Connect the Cardiology Dots

Michael H. Wilson

August 15, 2016

News Opinion Conversations in Cardiology

Conversations in Cardiology: In the United States, Should TAVR Be Offered to a Low-Risk Patient?

July 11, 2016

News Daily News

Now You See It: FDA Approves Absorb Bioresorbable Scaffold

Michael O'Riordan

July 05, 2016

News Daily News

Prolonged Full-Dose Bivalirudin May Preserve Bleeding Benefit Without Upping Thrombotic Events After STEMI, Meta-Analysis Suggests

Yael L. Maxwell

June 20, 2016

Presentation TVT 2016

Transcatheter Mitral Repair and Replacement: State-of-the Art 2016

Presenter: Gregg W. Stone

June 16, 2016

News Daily News

PCI Continues to Carve Out a Share of Unprotected Left Main Disease in the Absence of Definitive Evidence

Todd Neale

June 08, 2016

Presentation Fellows 2016

State-of-the-Art in ACS and STEMI: Risk Stratification and Reperfusion Strategies

Presenter: Gregg Stone

April 15, 2016

Presentation Fellows 2016

Drug-Eluting Stents: Past, Present, and Future

Presenter: Gregg Stone

April 15, 2016

News Conference News ACC 2016

Sapien 3 Superior to Surgery Among Intermediate-Risk Patients in Observational Trial

Yael L. Maxwell

April 03, 2016

Presentation ACC 2016

Outcomes of the ABSORB Bioresorbable Vascular Scaffold in Very Small and Not Very Small Coronary Arteries: The ABSORB III randomized trial

Presenter: Gregg W. Stone

April 03, 2016

Presentation CHIP Florida 2016

Importance of Coronary Calcification in Complex PCI:Data and Devices

Presenter: Gregg W. Stone

April 01, 2016

News Daily News

AVB Absorb: Seguridad, Eficacia y Trombosis del Stent a Estudio en 2 Nuevos Análisis

Michael O'Riordan

March 30, 2016

News Daily News

Absorb BVS: Safety, Efficacy, and Stent Thrombosis Tackled in Two New Analyses

Michael O'Riordan

March 30, 2016

News Daily News

Absorb BVS：两项新研究解决了安全性、有效性和支架血栓问题

Michael O'Riordan

March 30, 2016

Advertisement

BIONICS: A Prospective, Randomized Trial of a Ridaforolimus-Eluting Coronary Stent vs a Zotarolimus-Eluting Stent in a More-Comers Population of Patients With Coronary Artery Disease

BIO-RESORT (TWENTE III): A Prospective, Randomized Three-Arm Trial Comparing Two Different Biodegradable Polymer-Based Drug-Eluting Stents and a Durable Polymer-Based Drug-Eluting Stent in an All-Comers Population of Patients With Coronary Artery Disease

ILUMIEN III (OPTIMIZE PCI): A Prospective, Randomized Trial of OCT-Guided vs IVUS-Guided vs Angio-Guided Stent Implantation in Patients With Coronary Artery Disease

TCT 2016: Inspiration and Perspiration Greet Left Main Stenting, Hoop Dreams, Valve Innovation, and Election Fever

Day or Night, STEMI Patients Receive Similar Levels of Quality Care

NORSTENT: Do Modern-day Bare-Metal Stents Stand Up to Drug-Eluting Stents?

One Map to Guide Them All: The Physician Who Hopes to Connect the Cardiology Dots

Conversations in Cardiology: In the United States, Should TAVR Be Offered to a Low-Risk Patient?

Now You See It: FDA Approves Absorb Bioresorbable Scaffold

Prolonged Full-Dose Bivalirudin May Preserve Bleeding Benefit Without Upping Thrombotic Events After STEMI, Meta-Analysis Suggests

Transcatheter Mitral Repair and Replacement: State-of-the Art 2016

PCI Continues to Carve Out a Share of Unprotected Left Main Disease in the Absence of Definitive Evidence

State-of-the-Art in ACS and STEMI: Risk Stratification and Reperfusion Strategies

Drug-Eluting Stents: Past, Present, and Future

Sapien 3 Superior to Surgery Among Intermediate-Risk Patients in Observational Trial

Outcomes of the ABSORB Bioresorbable Vascular Scaffold in Very Small and Not Very Small Coronary Arteries: The ABSORB III randomized trial

Importance of Coronary Calcification in Complex PCI:Data and Devices

AVB Absorb: Seguridad, Eficacia y Trombosis del Stent a Estudio en 2 Nuevos Análisis

Absorb BVS: Safety, Efficacy, and Stent Thrombosis Tackled in Two New Analyses

Absorb BVS：两项新研究解决了安全性、有效性和支架血栓问题

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content